ForumIAS LATEST
- SFG FRC 2027 | Program starts from 15th Dec. 2026 | Admissions open for Tranche-1 Entrance Test till 25th Oct. 2026 Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 21st October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News:Directorate General of Foreign Trade (DGFT) removed the export restrictions on 24 active pharmaceutical ingredients (API) and formulations. These include Vitamins B6, B1, B12, Neomycin, Erythromycin among others.
Facts:
- Background: Amid COVID-19 pandemic, the government had earlier restricted exports of 26 bulk drugs and their formulations to curb shortages in India.
Additional Facts:
Directorate General of Foreign Trade
- It is an attached office of the Ministry of Commerce and Industry and is headed by the Director -General of Foreign Trade.
- It is responsible for implementing the Foreign Trade Policy with the main objective of promoting India’s exports.
Bulk Drugs: The active chemical substances in powder form, the main ingredient in pharmaceuticals – chemicals having therapeutic value, used for the production of pharmaceutical formulations.
Active Pharmaceutical Ingredient (API): It is the part of any drug that produces the intended effects
